E. Krognes - Insider Trading & Ownership

Entity
Individual
Location
863 Mitten Road, Suite 102, Burlingame, CA
Summary
The estimated net worth of E. Krognes is at least $24.8M dollars as of November 4, 2024. E. Krognes is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $24.4M. E. Krognes is the Director of Guardant Health, Inc. and owns shares of Guardant Health, Inc. (GH) stock worth about $287K. E. Krognes is the Director of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $111K.
All Insider Reports
All Insider Reports

Ownership of E. Krognes

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DNLI Denali Therapeutics Inc. Director $24.4M -$3.6M -12.8% Sep 30, 2024
GH Guardant Health, Inc. Director $287K Oct 31, 2024
PLRX PLIANT THERAPEUTICS, INC. Director $111K Jun 13, 2024
GRTS Gritstone bio, Inc. Director Jun 16, 2023

Insider Transactions Reported by E. Krognes:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.